Skip to Main Content

Author Details

Douglas R Stewart
Clinical Genetics Branch, National Cancer Institute
2003
116
36
PMIDPaper TitleJournal TitlePublished Year
37246069Germline Exome Sequencing for Men with Testicular Germ Cell Tumor Reveals Coding Defects in Chromosomal Segregation and Protein-targeting Genes.Eur Urol2024
37688579Germline pathogenic variants in neuroblastoma patients are enriched in BARD1 and predict worse survival.J Natl Cancer Inst2024
37246069Germline Exome Sequencing for Men with Testicular Germ Cell Tumor Reveals Coding Defects in Chromosomal Segregation and Protein-targeting Genes.Eur Urol2024
37688579Germline pathogenic variants in neuroblastoma patients are enriched in BARD1 and predict worse survival.J Natl Cancer Inst2024
34331184Unusual phenotypes in patients with a pathogenic germline variant in DICER1.Fam Cancer2023
36137255Outcomes for Children With Type II and Type III Pleuropulmonary Blastoma Following Chemotherapy: A Report From the International PPB/<i>DICER1</i> Registry.J Clin Oncol2023
36424733Health-related quality of life in children and adolescents with pleuropulmonary blastoma: A report from the International PPB/DICER1 Registry.Pediatr Blood Cancer2023
37585199Estimated Prevalence, Tumor Spectrum, and Neurofibromatosis Type 1-Like Phenotype of CDKN2A-Related Melanoma-Astrocytoma Syndrome.JAMA Dermatol2023
38084291Specifications of the ACMG/AMP Variant Classification Guidelines for Germline <i>DICER1</i> Variant Curation.Hum Mutat2023
37883719Intronic Germline <i>DICER1</i> Variants in Patients With Sertoli-Leydig Cell Tumor.JCO Precis Oncol2023
37347242ACMG SF v3.2 list for reporting of secondary findings in clinical exome and genome sequencing: A policy statement of the American College of Medical Genetics and Genomics (ACMG).Genet Med2023
36966234Cancer in Costello syndrome: a systematic review and meta-analysis.Br J Cancer2023
36896180<i>DICER1</i> RNase IIIb domain mutations trigger widespread miRNA dysregulation and MAPK activation in pediatric thyroid cancer.Front Endocrinol (Lausanne)2023
37386403Increase in power by obtaining 10 or more controls per case when type-1 error is small in large-scale association studies.BMC Med Res Methodol2023
36696392Inflated expectations: Rare-variant association analysis using public controls.PLoS One2023
36747619Germline pathogenic variants in 786 neuroblastoma patients.medRxiv2023
36692560Estimated Prevalence and Clinical Manifestations of UBA1 Variants Associated With VEXAS Syndrome in a Clinical Population.JAMA2023
36547466The designated record set for clinical genetic and genomic testing: A points to consider statement of the American College of Medical Genetics and Genomics (ACMG).Genet Med2023
36541551Alternative lengthening of telomeres (ALT) in pediatric high-grade gliomas can occur without ATRX mutation and is enriched in patients with pathogenic germline mismatch repair (MMR) variants.Neuro Oncol2023
36541021Type I and Ir pleuropulmonary blastoma (PPB): A report from the International PPB/DICER1 Registry.Cancer2023
37492101OpenPBTA: The Open Pediatric Brain Tumor Atlas.Cell Genom2023
37490054Management of individuals with germline pathogenic/likely pathogenic variants in CHEK2: A clinical practice resource of the American College of Medical Genetics and Genomics (ACMG).Genet Med2023
34331184Unusual phenotypes in patients with a pathogenic germline variant in DICER1.Fam Cancer2023
38084291Specifications of the ACMG/AMP Variant Classification Guidelines for Germline <i>DICER1</i> Variant Curation.Hum Mutat2023
37490054Management of individuals with germline pathogenic/likely pathogenic variants in CHEK2: A clinical practice resource of the American College of Medical Genetics and Genomics (ACMG).Genet Med2023
37585199Estimated Prevalence, Tumor Spectrum, and Neurofibromatosis Type 1-Like Phenotype of CDKN2A-Related Melanoma-Astrocytoma Syndrome.JAMA Dermatol2023
37883719Intronic Germline <i>DICER1</i> Variants in Patients With Sertoli-Leydig Cell Tumor.JCO Precis Oncol2023
37492101OpenPBTA: The Open Pediatric Brain Tumor Atlas.Cell Genom2023
37386403Increase in power by obtaining 10 or more controls per case when type-1 error is small in large-scale association studies.BMC Med Res Methodol2023
37347242ACMG SF v3.2 list for reporting of secondary findings in clinical exome and genome sequencing: A policy statement of the American College of Medical Genetics and Genomics (ACMG).Genet Med2023
36966234Cancer in Costello syndrome: a systematic review and meta-analysis.Br J Cancer2023
36696392Inflated expectations: Rare-variant association analysis using public controls.PLoS One2023
36547466The designated record set for clinical genetic and genomic testing: A points to consider statement of the American College of Medical Genetics and Genomics (ACMG).Genet Med2023
36747619Germline pathogenic variants in 786 neuroblastoma patients.medRxiv2023
36692560Estimated Prevalence and Clinical Manifestations of UBA1 Variants Associated With VEXAS Syndrome in a Clinical Population.JAMA2023
36541551Alternative lengthening of telomeres (ALT) in pediatric high-grade gliomas can occur without ATRX mutation and is enriched in patients with pathogenic germline mismatch repair (MMR) variants.Neuro Oncol2023
36541021Type I and Ir pleuropulmonary blastoma (PPB): A report from the International PPB/DICER1 Registry.Cancer2023
36424733Health-related quality of life in children and adolescents with pleuropulmonary blastoma: A report from the International PPB/DICER1 Registry.Pediatr Blood Cancer2023
36896180<i>DICER1</i> RNase IIIb domain mutations trigger widespread miRNA dysregulation and MAPK activation in pediatric thyroid cancer.Front Endocrinol (Lausanne)2023
36137255Outcomes for Children With Type II and Type III Pleuropulmonary Blastoma Following Chemotherapy: A Report From the International PPB/<i>DICER1</i> Registry.J Clin Oncol2023
34415349Another Weak Link in the Electron Transport Chain: Variants in SUCLG2 and Risk for Pheochromocytoma and Paraganglioma.J Natl Cancer Inst2022
35805029A Genome-First Approach to Estimate Prevalence of Germline Pathogenic Variants and Risk of Pancreatic Cancer in Select Cancer Susceptibility Genes.Cancers (Basel)2022
35802134ACMG SF v3.1 list for reporting of secondary findings in clinical exome and genome sequencing: A policy statement of the American College of Medical Genetics and Genomics (ACMG).Genet Med2022
35405740Examination of Genetic Susceptibility in Radiation-Associated Meningioma.Radiat Res2022
36409970Gene-Level Associations in Patients With and Without Pathogenic Germline Variants in <i>CDKN2A</i> and Pancreatic Cancer.JCO Precis Oncol2022
36533693Cancer incidence and surveillance strategies in individuals with RASopathies.Am J Med Genet C Semin Med Genet2022
33782093Testicular Sertoli cell tumour and potentially testicular Leydig cell tumour are features of <i>DICER1</i> syndrome.J Med Genet2022
34854873Insights Into Immune-Mediated Disease and Cancer Risk-Delivering on the Promise of UK Biobank Big Data.JAMA Oncol2022
34599283DICER1 tumor predisposition syndrome: an evolving story initiated with the pleuropulmonary blastoma.Mod Pathol2022
34415349Another Weak Link in the Electron Transport Chain: Variants in SUCLG2 and Risk for Pheochromocytoma and Paraganglioma.J Natl Cancer Inst2022
  • 1 - 50 of 232

Recommended Authors

University of Toronto
Career Start Year 2015
Number of shared co-authors 3
Toronto General Hospital
Career Start Year 2014
Number of shared co-authors 3
St. Jude Children's Research Hospital
Career Start Year 2014
Number of shared co-authors 5
Invitae Corporation
Career Start Year 2013
Number of shared co-authors 1
University of Pennsylvania
Career Start Year 2010
Number of shared co-authors 3
Children's Hospital Los Angeles
Career Start Year 2009
Number of shared co-authors 7
Nationwide Children's Hospital
Career Start Year 2009
Number of shared co-authors 2
Nationwide Children's Hospital
Career Start Year 2009
Number of shared co-authors 7
Curie Institute Hospital Group
Career Start Year 2008
Number of shared co-authors 6
Emory School of Medicine
Career Start Year 2008
Number of shared co-authors 4
Great Ormond Street Hospital
Career Start Year 2006
Number of shared co-authors 8
Children's Cancer Institute, Lowy Cancer Research Centre
Career Start Year 2006
Number of shared co-authors 11
H. Lee Moffitt Cancer Center and Research Institute
Career Start Year 2005
Number of shared co-authors 14
QIMR Berghofer Medical Research Institute
Career Start Year 2005
Number of shared co-authors 6
Institute for Genomic Medicine, Nationwide Children's Hospital
Career Start Year 2005
Number of shared co-authors 8
Guardant Health Inc.
Career Start Year 2004
Number of shared co-authors 1
Memorial Sloan Kettering Cancer Center
Career Start Year 2004
Number of shared co-authors 10
Children's Hospital of Philadelphia
Career Start Year 2004
Number of shared co-authors 18
Texas Children's Hospital and Baylor College of Medicine
Career Start Year 2004
Number of shared co-authors 11
Mayo Clinic College of Medicine and Science
Career Start Year 2001
Number of shared co-authors 10
Northwestern University Feinberg School of Medicine
Career Start Year 1998
Number of shared co-authors 7
Centene Center for Health Transformation, Centene Corporation
Career Start Year 1998
Number of shared co-authors 9
Guy's and St Thomas' NHS Foundation Trust
Career Start Year 1998
Number of shared co-authors 9
Harvard T.H. Chan School of Public Health
Career Start Year 1996
Number of shared co-authors 1
Texas Children's Hospital
Career Start Year 1996
Number of shared co-authors 40
University of Oxford
Career Start Year 1996
Number of shared co-authors 11
Mayo Clinic
Career Start Year 1992
Number of shared co-authors 18
Baylor College of Medicine
Career Start Year 1992
Number of shared co-authors 44
Yale School of Medicine
Career Start Year 1989
Number of shared co-authors 11
Baylor College of Medicine
Career Start Year 1984
Number of shared co-authors 35

Collaborators

Clinical Genetics Branch, National Cancer Institute
Co-authored papers 26
Co-authored papers 23
Co-authored papers 11
Clinical Genetics Branch, National Cancer Institute (NCI)
Co-authored papers 11
National Cancer Institute, National Institutes of Health
Co-authored papers 10
National Cancer Institute
Co-authored papers 8
National Cancer Institute
Co-authored papers 7
Frederick National Laboratory for Cancer Research
Co-authored papers 7
Frederick National Laboratory for Cancer Research
Co-authored papers 7
Perelman School of Medicine, University of Pennsylvania, USA Abramson Cancer Center
Co-authored papers 6
Illumina Inc.
Co-authored papers 6
Co-authored papers 6
National Cancer Institute, National Institutes of Health
Co-authored papers 6
National Cancer Institute
Co-authored papers 6
National Cancer Institute
Co-authored papers 6
Center for Cancer Research, National Cancer Institute
Co-authored papers 5
Oregon Health & Science University (OHSU)
Co-authored papers 5
National Institutes of Health
Co-authored papers 5
The University of North Carolina at Chapel Hill
Co-authored papers 5
National Human Genome Research Institute, National Institutes of Health
Co-authored papers 5
Children's Hospital of Philadelphia
Co-authored papers 5
Boston Children's Hospital
Co-authored papers 5
Northwestern University Feinberg School of Medicine.
Co-authored papers 5
National Cancer Institute
Co-authored papers 5
Frederick National Laboratory for Cancer Research (FNLCR), Inc.
Co-authored papers 4
Geisinger Medical Center
Co-authored papers 4
Children's Hospital of Philadelphia
Co-authored papers 4
Stanford University
Co-authored papers 4
National Cancer Institute
Co-authored papers 4
National Human Genome Research Institute, National Institutes of Health
Co-authored papers 4